Abstract
Little is known about activated immune-inflammatory pathways and interleukin-6 (IL-6) in the development of fatigue and/or depression in patients with end-stage renal disease on chronic hemodialysis (HD).
Original language | English |
---|---|
Pages (from-to) | N/A-N/A |
Journal | Journal of Pain and Symptom Management |
DOIs | |
Publication status | Published - 2014 |
Keywords
- Hemodialysis
- depression
- fatigue
- inflammation
- interleukin-6